Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EVAX Evaxion Biotech A/S

Pre-Mkt 09-04 08:58:35 EDT

3.08

+0.01

+0.33%

盘前3.13

+0.05+1.62%

08:30 EDT

High3.15	Low3.07	Vol39.61K
Open3.10	D1 Closing3.07	Amplitude2.72%
Mkt Cap25.57M	Tradable Cap17.04M	Total Shares8.30M
T/O122.21K	T/O Rate0.72%	Tradable Shares5.53M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EVAX","market":"US","secType":"STK","nameCN":"Evaxion Biotech A/S","latestPrice":3.08,"timestamp":1788465600000,"preClose":3.07,"halted":0,"volume":39611,"hourTrading":{"tag":"盘前","latestPrice":3.13,"preClose":3.08,"latestTime":"08:30 EDT","volume":197,"amount":618.6681378,"timestamp":1788525049568,"change":0.05,"changeRate":0.016234,"amplitude":0.006364},"delay":0,"changeRate":0.0032573289902280886,"floatShares":5531900,"shares":8302700,"eps":-1.088593,"marketStatus":"Pre-Mkt","change":0.01,"latestTime":"09-04 08:58:35 EDT","open":3.1,"high":3.15,"low":3.0666,"amount":122205.7617781,"amplitude":0.027166,"askPrice":3.4,"askSize":400,"bidPrice":2.87,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-1.088593,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788528600000},"marketStatusCode":1,"adr":0,"adrRate":50,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":3.08,"preHourTrading":{"tag":"盘前","latestPrice":3.13,"preClose":3.08,"latestTime":"08:30 EDT","volume":197,"amount":618.6681378,"timestamp":1788525049568,"change":0.05,"changeRate":0.016234,"amplitude":0.006364},"postHourTrading":{"tag":"盘后","latestPrice":3.08,"preClose":3.08,"latestTime":"19:30 EDT","volume":14,"amount":43.44,"timestamp":1788478207031,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.46789324535429305,"impliedVol":2.1042,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/EVAX/tweets","defaultTab":"tweets","newsList":[{"id":"2664213339","title":"Evaxion Biotech Boosts Share Capital With August 2026 ATM ADS Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2664213339","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664213339?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:28","pubTimestamp":1788521319,"startTime":"0","endTime":"0","summary":"Evaxion Biotech ( ($EVAX) ) has shared an update. Between August 19 and August 21, 2026, Evaxion A/S raised $2.11 million in net proceeds through t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-boosts-share-capital-with-august-2026-atm-ads-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-boosts-share-capital-with-august-2026-atm-ads-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","XBI","BK4139","BK4585","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886803","title":"European Equities Traded in the US as American Depositary Receipts Edge Higher in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886803","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886803?lang=en_us&edition=fundamental","pubTime":"2026-09-03 23:27","pubTimestamp":1788449236,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were edging higher late Thursday morning, rising 0.29% to 1,969.29 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by accommodations booking site trivago  and biopharmaceutical company Cellectis , which rose 6.2% and 6% respectively. They were followed by software firm SAP  and biotech firm Evaxion , which were up 3.6% and 1.3% respectively.The decliners from continental Europe were led by healthcare tech company Royal Philips  and telecommunications company Nokia , which fell 2.5% and 2.2% respectively. They were followed by petroleum refiner Equinor  and consumer goods company Unilever , which were down 1.2% and 0.5% respectively.The gainers from the UK were led by communications company WPP  and telecommunications operator Vodafone Group , which climbed 7.1% and 3.4% respectively. They were followed by software firm Endava , which advanced 2.9%.The decliners from the UK and Ireland we","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4134","DEO","BK4077","EPV","ULVR.UK","DAVA.AU","EQNR","WPP","AFG","LU0300736492.USD","TRVG","BK4528","BK4532","BK4169","BHP.AU","IE00BMPRXN33.USD","UL","UN","BK4117","BK4107","SLX","BK4585","DGE.UK","BK7511","LNOK","BK4023","DAVA","BK4183","NCNA","WPP.AU","LU0084288595.USD","BHP","BK4588","COAL","LU0124676726.USD","EVAX","PHG","LU0006061336.USD","VOD","IEUR","LU0300736062.USD","BK4082","BK4168","SAP","BK4132","CLLS","BK4547","BK4592","NOK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664081008","title":"European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2664081008","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664081008?lang=en_us&edition=fundamental","pubTime":"2026-09-02 23:13","pubTimestamp":1788362021,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.50% to 1,960.43 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and semiconductor company Sequans Communications , which rose 4% and 3.6% respectively. They were followed by pharmaceutical company Novo Nordisk  and lender ING Group , which were up 3.5% and 2.9% respectively.The decliners from continental Europe were led by internet browser company Opera  and petroleum refiner Equinor , which dropped  2.3% and 1.5% respectively. They were followed by telecommunications companies Nokia  and Ericsson , which lost 0.8% and 0.7% respectively.The gainers from the UK were led by hospitality company InterContinental Hotels Group  and biopharmaceutical company Bicycle Therapeutics , which advanced 4.1% and 3.1% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals  and mining company BHP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4201","BK4023","BK4168","BK4505","BHP","BK4585","BCYC","NVO","BK4142","PSO","OPRA","LFGY","NVOC","TRIB","EQNR","LU1093756325.SGD","BK4204","EVAX","BK4009","SQNS","IE00BMPRXR70.SGD","IE00BMPRXN33.USD","LU0154236417.USD","LU0006061336.USD","BK4207","ING","IHG","BK4139","LU0300736492.USD","COAL","MREO","BK4007","IE00BZ1G4Q59.USD","BK4588","BK4020","NOK","THNR","BK4111","BK4515","LNOK","BK4547","NVOH","OZEM","PPH","WPP","BK4532","BK4591","SLX","NVOX","BK4141","BK4082","ERIC","BK4599","IE00BKVL7J92.USD","LU1093756168.USD","LU0300736062.USD","BDRX","BK4554"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663004961","title":"European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2663004961","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663004961?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:12","pubTimestamp":1788189152,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week slightly lower late Monday morning, declining 0.12% to 1,952.52 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical company Ascendis Pharma  and 3D printer company Materialise , which rose 6.6% and 2.8%, respectively. They were followed by petroleum refiner Equinor  and oil and gas company Eni , which were up 2.7% and 2.6%, respectively.The decliners from continental Europe were led by internet browser company Opera  and biotech firm Evaxion , which fell 1.9% and 1.7% respectively. They were followed by telecommunications company Nokia  and accommodations booking site trivago , which were down 1.3% and 1.2% respectively.The gainers from the UK were led by biopharmaceutical company Mereo BioPharma Group  and software firm Endava , which advanced 14% and 1.9% respectively. They were followed by oil and gas companies BP  and Shell , which increased 1.3% and 0.9","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PXJ","BPH","IEO","DAVA","AKTX","DBC","DBE","ERX","ASND","BDRX","LU0109394709.USD","DIG","IXC","PRNT","TRVG","LU1829250122.USD","SHEH","LU0278409577.USD","E","SLN","IEUR","LU0648005311.SGD","LU0098860793.USD","EQNR","MREO","XES","OPRA","LNOK","DAVA.AU","PXE","USE","EVAX","BP","FTXN","VDE","WTIU","EPV","LU2236285917.USD","GUSH","DRIP","NOK","MTLS","SHEL","LFGY","LU0084288595.USD","MEDI","NCNA","AFG","DRLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661626792","title":"Analysts’ Top Healthcare Picks: Evaxion Biotech (EVAX), Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661626792","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661626792?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:10","pubTimestamp":1787310632,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Evaxion Biotech (EVAX) and Ultragenyx Pharmaceutical...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-evaxion-biotech-evax-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-evaxion-biotech-evax-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","XLV","BK4588","BK4585","HCSG","BK4137","EVAX","XBI","LU0029874061.USD","LU0128526141.USD","BK4139","RARE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660628747","title":"Evaxion A/S Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2660628747","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660628747?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:32","pubTimestamp":1787232752,"startTime":"0","endTime":"0","summary":"Evaxion A/S reports results for the quarter ended June 30 - Earnings SummaryEvaxion A/SEVAX.OQreported a quarterly adjusted loss of 50 cents per share for the quarter ended June 30, higher than the sa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL8N44H104:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660528924","title":"Denmark's Evaxion Q2 Net Loss Narrows on Lower Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2660528924","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660528924?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:40","pubTimestamp":1787226057,"startTime":"0","endTime":"0","summary":"Denmark's Evaxion Q2 net loss narrows on lower expensesOverviewDenmark vaccine developer posted Q2 net loss narrowed from last year on lower financial expensesCompany reported no revenue for Q2, consi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0FS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660899162","title":"Evaxion Q2 FY26 Net Loss Narrows to USD 3.7 Million; Revenue Posts no Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2660899162","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660899162?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:30","pubTimestamp":1787225438,"startTime":"0","endTime":"0","summary":"Evaxion Q2 FY26 net loss narrows to USD 3.7 million; revenue posts no revenueEvaxion reported Q2 2026 net loss of USD 3.7 million, improving from a USD 4.8 million loss in Q2 2025.Operating loss narro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL5z8Ybd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4139","BK4112","LU2095319765.USD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BN0W2V16.EUR","LU0314104364.USD","BK4588","BCDF","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","NDAQ","LU2210150020.SGD","IE00BN0W2W23.USD","EVAX","IE00B3QW5Z07.USD","BK4585","IE00BQXX3F31.USD","SG9999014039.USD","SG9999014013.SGD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","SG9999014005.SGD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660289986","title":"Evaxion Q2 Operating Income USD -3.846 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660289986","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660289986?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:30","pubTimestamp":1787225401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXN5RFPW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660028960","title":"Evaxion Q2 Pretax Profit USD -3.933 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660028960","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660028960?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:30","pubTimestamp":1787225401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXN5RFPW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660920289","title":"Press Release: Evaxion Announces Business Update and Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660920289","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660920289?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:30","pubTimestamp":1787225400,"startTime":"0","endTime":"0","summary":"COPENHAGEN, Denmark, August 20, 2026 - Evaxion A/S  , a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology platform, provides business update and announces second quarter 2026 financial results.Business highlights Evaxion is making steady progress towards completing its strategic milestones for 2026. Highlights include:-- Announcing the upcoming presentation of three-year clinical data for. -- Presentation of new data for EVX-04, an off-the-shelf cancer vaccine for. -- Expansion and refocusing of our R&D pipeline with EVX-05, a novel. -- Presentation of new data for cytomegalovirus  vaccine candidate. -- Winning the 2026 Prix Galien UK Award for Best digital health solution. -- Cash runway unchanged with cash at hand to fund operations into the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","AGIX","BK4555","03160","VTHR","BK4604","BK4588","CHAT","BK4139","ARTY","EVX","AIPO","QTOC","TM","BK4099","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421716","title":"European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421716","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421716?lang=en_us&edition=fundamental","pubTime":"2026-08-19 23:18","pubTimestamp":1787152727,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.68% to 1,973.64 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm BioNTech  and biopharmaceutical company Grifols , which advanced 24% and 5.6% respectively. They were followed by semiconductor company Sequans Communications  and biopharmaceutical company argenx , which rose 3.3% and 3% respectively.The decliners from continental Europe were led by internet browser company Opera  and biotech firm Evaxion , which fell 7.9% and 6% respectively. They were followed by accommodations booking site Trivago  and telecommunications company Nokia , which were down 4.3% and 1.6% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics  and mining company BHP Group , which increased 9.2% and 4.5% respectively. They were followed by software firm Endava  and biopharmaceutical company Bicycle Therapeutics , w","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IEUR","AFG","LFGY","EPV","TBXU","DAVA","LU0109394709.USD","BK4588","LU0006061336.USD","BK4547","IE00BMPRXN33.USD","LU0300736062.USD","COAL","IE00BJT1NW94.SGD","BHP","IE00BJJMRZ35.SGD","BDRX","LU1983260115.SGD","IBB","IE00B2B36J28.USD","AUTL","FMED","LU0889565916.HKD","NOK","LNOK","BCYC","SQNS","OPRA","GRFS","IE00B4R5TH58.HKD","IE0009355771.USD","ARGX","BNTX","BK4548","BK4117","NVIB","SNN","DAVA.AU","LU0823416689.USD","LU0648005311.SGD","LU2324357040.USD","PUK","SLX","BK4141","XBIX","BK4585","BHP.AU","TRVG","TRIB","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660959154","title":"European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2660959154","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660959154?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:13","pubTimestamp":1787066007,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower in late Tuesday morning trading, declining 0.50% to 1,960.50 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by software firm SAP  and pharmaceutical company Sanofi , which increased 1.7% and 1.6% respectively. They were followed by healthcare tech company Royal Philips  and biopharmaceutical company DBV Technologies , which were up 1.5% and 1.3% respectively.The decliners from continental Europe were led by telecommunications company Nokia  and biopharmaceutical company Cellectis , which lost 3.8% and 2.9% respectively. They were followed by biotech firm Evaxion  and furniture maker Natuzzi , which dropped 1.6% and 1.5% respectively.The gainers from the UK were led by software firm Endava  and communications company WPP , which advanced 4.1% and 2.6% respectively. They were followed by pharmaceutical company AstraZeneca  and biotech company Trinity Biotech , which ro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443382.USD","NTZ","IEUR","BK4547","TRIB","WPP","DAVA.AU","WPP.AU","BK4568","LU0708994859.HKD","AZNH","AFG","EVAX","LU0006061336.USD","BK4528","EPV","AZN","BK4007","LU0432979614.USD","BK4588","SLN","LU2237443978.SGD","BK4505","LU0029864427.USD","SAP","BCS","LU0058720904.USD","BK4134","PHG","LU2468319806.SGD","LNOK","LU2462157665.USD","LU0648005311.SGD","LU0320765992.SGD","BK4023","BK4009","NOK","BK4117","BK4139","SNY","LU0128525929.USD","LU2237443549.SGD","CLLS","AKTX","MREO","BK4521","LU2089984988.USD","DBVT","LU2237443895.HKD","DAVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660467894","title":"Evaxion A/S Expected to Post a Loss of 31 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2660467894","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660467894?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:32","pubTimestamp":1787056327,"startTime":"0","endTime":"0","summary":"Evaxion A/S <EVAX.OQ> expected to post a loss of31cents a share - Earnings PreviewEvaxion A/SEVAX.OQEVAX.Ois expected to  show a fall in quarterly revenue when it reports  results on August 20 for the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL8N44F0OL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660876487","title":"Evaxion a/S: Costs Related to Evx-05 Captured Within Co's Existing Budgets not Impacting on Cash Runway, Which Continues to Stretch into H2'2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2660876487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660876487?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:08","pubTimestamp":1786968488,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0EM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487826","title":"Evaxion a/S - Expands Pipeline of Cancer Vaccine Programs with Evx-05 Against Brain Cancer Glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487826","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487826?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:08","pubTimestamp":1786968488,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0EM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660892487","title":"Evaxion Adds EVX-05 Off-the-Shelf Glioblastoma Vaccine Program to R&D Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2660892487","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660892487?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:06","pubTimestamp":1786968376,"startTime":"0","endTime":"0","summary":"Evaxion adds EVX-05 off-the-shelf glioblastoma vaccine program to R&D pipelineEvaxion added EVX-05, an off-the-shelf therapeutic vaccine program for glioblastoma, designed using its AI-Immunology plat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDLbjFrbM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660207482","title":"Evaxion to Host Q2 Business Update, Financial Results Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2660207482","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660207482?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:01","pubTimestamp":1786968093,"startTime":"0","endTime":"0","summary":"Evaxion to host Q2 business update, financial results call and webcastEvaxion will host a conference call and webcast on Aug. 20 at 8:30 a.m. ET to present its Q2 2026 business update and financial re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDLc9QH55:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","LU2210149790.SGD","LU2095319765.USD","BK4139","IE00B3QW5Z07.USD","LU0314104364.USD","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014005.SGD","SG9999014039.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4585","IE00BKPKM429.USD","SG9999014013.SGD","BK4588","IE00BN0W2T93.GBP","BK4112","EVAX","SG9999014021.USD","BCDF","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659140268","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2659140268","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659140268?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:08","pubTimestamp":1786720082,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower late Friday morning, declining 0.35% to 1,962.14 on the S&P Europe Select ADR Index, which is up 0.17% for the we","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TBXU","BK4201","AKTX","BPH","FTXN","FMED","SHEL","LU0889565916.HKD","BCYC","DBC","DRIP","EQNR","AFG","BK4107","EVAX","LU0320765646.SGD","ERX","SQNS","DBE","GUSH","USE","BP","AUTL","SHEH","ARGX","DBVT","NCNA","PXJ","IEO","NOK","TRIB","CLLS","LNOK","BK4547","WTIU","XES","EPV","IE0009355771.USD","VDE","PXE","IXC","IEUR","DIG","DRLL","LU1983260115.SGD","IBB","LU2324357040.USD","BDRX","E"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659146729","title":"Evaxion to Report Q2 2026 Results, Host Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2659146729","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659146729?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:00","pubTimestamp":1786708817,"startTime":"0","endTime":"0","summary":"Evaxion to report Q2 2026 results, host conference call and webcastEvaxion schedules a business update with second-quarter 2026 financial results for Aug. 20, 2026, before the Nasdaq CM open.Managemen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDLVJcBN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","BCDF","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU2095319765.USD","BK4112","IE00BN0W2V16.EUR","BK4139","IE00B64PRP62.GBP","SG9999014021.USD","BK4585","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014005.SGD","SG9999014039.USD","SG9999014013.SGD","BK4588","IE00BN0W2W23.USD","EVAX","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evaxion.ai","stockEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":0.0441},{"period":"3month","weight":-0.1324},{"period":"6month","weight":-0.0435},{"period":"1year","weight":0.1892},{"period":"ytd","weight":-0.3543}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1499},{"period":"1year","weight":0.2011},{"period":"ytd","weight":0.1338}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.312391},{"month":2,"riseRate":0,"avgChangeRate":-0.075072},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.067423},{"month":4,"riseRate":0.666667,"avgChangeRate":0.093874},{"month":5,"riseRate":0.333333,"avgChangeRate":0.041103},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.074845},{"month":7,"riseRate":0.333333,"avgChangeRate":0.03566},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.030304},{"month":9,"riseRate":1,"avgChangeRate":0.168753},{"month":10,"riseRate":0.4,"avgChangeRate":0.102065},{"month":11,"riseRate":0.2,"avgChangeRate":-0.236379},{"month":12,"riseRate":0,"avgChangeRate":-0.21322}],"exchange":"NASDAQ","name":"Evaxion Biotech A/S","nameEN":"Evaxion Biotech A/S","securityTypeName":"DR","adrRate":"1:50"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evaxion Biotech A/S,EVAX,Evaxion Biotech A/S股票,Evaxion Biotech A/S股票老虎,Evaxion Biotech A/S股票老虎国际,Evaxion Biotech A/S行情,Evaxion Biotech A/S股票行情,Evaxion Biotech A/S股价,Evaxion Biotech A/S股市,Evaxion Biotech A/S股票价格,Evaxion Biotech A/S股票交易,Evaxion Biotech A/S股票购买,Evaxion Biotech A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction